This article is more than 5 years old. Information may no longer be current.

DEKA Medical receives FDA clearance for light-, laser-based skin treatment, hair reduction

DEKA Medical announced it has received FDA clearance for its combined laser- and light-based hair reduction and skin treatment for benign pigmented lesions, wrinkles and photocoagulation of vascular lesions.

The Synchro REPLA:Y uses three different light sources, a 755 nm Alexandrite laser, a 1064 nm Nd:YAG laser and an intense pulsed light, according to a press release. The lasers feature spot sizes from 2.5 mm to 20 mm, while the intense pulsed light includes five filters, from 500 nm to 650 nm lower cut-off wavelength.

Alexandrite is considered the most effective laser source for hair reduction for fair skin, while the Nd:YAG laser is widely used for dark skin treatment, the release said.

“The energies, varying pulse widths and pulse shape and large (20 mm) spot sizes represent an advancement in technology that results in faster, better tolerated and more reliable treatments,” Martin Kassir, MD, FAAD, fellow, American Society for Laser Medicine and Surgery, and director of Kassir Dermatology, Dallas, said in the release.